Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
TLPH Talphera Inc.
- Stocks
- Healthcare
- NASDAQ: TLPH
Price (delayed)
$0.5509
Market cap
$9.42M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.5
Enterprise value
$7.08M
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known
Highlights
TLPH's EPS has surged by 61% year-on-year and by 23% since the previous quarter
TLPH's net income is up by 29% YoY and by 17% from the previous quarter
The quick ratio has surged by 61% year-on-year but it has declined by 17% since the previous quarter
TLPH's gross profit has shrunk by 100% QoQ and by 100% YoY
TLPH's revenue has shrunk by 100% QoQ and by 100% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.acelrx.com
Key stats
What are the main financial stats of TLPH
Market
Valuations
Earnings
Shares outstanding
17.1M
Market cap
$9.42M
Enterprise value
$7.08M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.17
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$15.25M
Net income
-$13M
EBIT
-$13M
EBITDA
-$13M
Free cash flow
-$12.68M
Per share
Balance sheet
Liquidity
EPS
-$0.5
EPS diluted
-$0.5
Free cash flow per share
-$0.49
Book value per share
$0.47
Revenue per share
$0
TBVPS
$0.71
Total assets
$18.24M
Total liabilities
$10.24M
Debt
$6.53M
Equity
$8M
Working capital
$6.77M
Debt to equity
0.82
Current ratio
3.56
Quick ratio
3.35
Net debt/EBITDA
0.18
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-56%
Return on equity
-111.4%
Return on invested capital
-85%
Return on capital employed
-83.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TLPH stock price
How has the Talphera stock price performed over time
Intraday
6.97%
1 week
7.68%
1 month
12.41%
1 year
-47.03%
YTD
5.11%
QTD
11.29%
Financial performance
How have Talphera's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$15.25M
Net income
-$13M
Gross margin
N/A
Net margin
N/A
TLPH's gross profit has shrunk by 100% QoQ and by 100% YoY
TLPH's revenue has shrunk by 100% QoQ and by 100% YoY
TLPH's net income is up by 29% YoY and by 17% from the previous quarter
Talphera's operating income has increased by 10% YoY and by 8% QoQ
Price vs fundamentals
How does TLPH's price correlate with its fundamentals
Growth
What is Talphera's growth rate over time
Valuation
What is Talphera stock price valuation
P/E
N/A
P/B
1.17
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
TLPH's EPS has surged by 61% year-on-year and by 23% since the previous quarter
TLPH's equity is down by 43% YoY and by 17% from the previous quarter
The P/B is 2.5% less than the last 4 quarters average of 1.2
TLPH's revenue has shrunk by 100% QoQ and by 100% YoY
Efficiency
How efficient is Talphera business performance
The company's return on invested capital has surged by 66% YoY and by 21% QoQ
TLPH's ROA is up by 33% year-on-year and by 15% since the previous quarter
The company's return on equity rose by 14% YoY and by 6% QoQ
Dividends
What is TLPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TLPH.
Financial health
How did Talphera financials performed over time
Talphera's total assets is 78% higher than its total liabilities
TLPH's total liabilities has soared by 63% YoY but it is down by 10% QoQ
The quick ratio has surged by 61% year-on-year but it has declined by 17% since the previous quarter
Talphera's debt is 18% less than its equity
TLPH's equity is down by 43% YoY and by 17% from the previous quarter
The debt to equity has grown by 21% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.